Aberrant cellular differentiation and migration in renal and pulmonary tuberous sclerosis complex

被引:14
作者
Astrinidis, A
Henske, EP
机构
[1] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Human Genet Working Grp, Philadelphia, PA 19111 USA
关键词
D O I
10.1177/08830738040190091201
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This review is focused on pathways and mechanisms that might provide molecular links between the pathogenesis of renal and pulmonary disease in tuberous sclerosis complex and the pathogenesis of the neurologic manifestations of tuberous sclerosis complex. Tuberous sclerosis complex is an autosomal dominant disorder in which the manifestations can include seizures; mental retardation; autism; benign tumors of the brain, retina, skin, and kidneys; and pulmonary lymphan-giomyomatosis. Lymphangiomyomatosis is a life-threatening lung disease affecting almost exclusively young women. Genetic data have demonstrated that the cells giving rise to renal angiomyolipomas, the most frequent tumor type in patients with tuberous sclerosis complex, exhibit differentiation plasticity. Genetic studies have also shown that the benign smooth muscle cells of angiomyolipomas and pulmonary lymphangiomyomatosis have the ability to migrate or metasta-size to other organs. These findings indicate that hamartin and tuberin play functional roles in the regulation of cell migration and differentiation. The biochemical pathways responsible for these effects are not yet fully understood but might involve dysregulation of the small guanosine triphosphatase Rho. Similar pathways might contribute to aberrant neuronal differentiation and migration in tuberous sclerosis complex.
引用
收藏
页码:710 / 715
页数:6
相关论文
共 42 条
  • [1] PAK3 mutation in nonsyndromic X-linked mental retardation
    Allen, KM
    Gleeson, JG
    Bagrodia, S
    Partington, MW
    MacMillan, JC
    Cerione, RA
    Mulley, JC
    Walsh, CA
    [J]. NATURE GENETICS, 1998, 20 (01) : 25 - 30
  • [2] Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration
    Astrinidis, A
    Cash, TP
    Hunter, DS
    Walker, CL
    Chernoff, J
    Henske, EP
    [J]. ONCOGENE, 2002, 21 (55) : 8470 - 8476
  • [3] Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis
    Astrinidis, A
    Khare, L
    Carsillo, T
    Smolarek, T
    Au, KS
    Northrup, H
    Henske, EP
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (01) : 55 - 57
  • [4] Lymphangioleiomyomatosis: Abdominopelvic CT and US findings
    Avila, NA
    Kelly, JA
    Chu, SC
    Dwyer, AJ
    Moss, J
    [J]. RADIOLOGY, 2000, 216 (01) : 147 - 153
  • [5] Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
    Carsillo, T
    Astrinidis, A
    Henske, EP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) : 6085 - 6090
  • [6] PULMONARY TUBEROUS SCLEROSIS
    CASTRO, M
    SHEPHERD, CW
    GOMEZ, MR
    LIE, JT
    RYU, JH
    [J]. CHEST, 1995, 107 (01) : 189 - 195
  • [7] Chan CC, 1999, ARCH OPHTHALMOL-CHIC, V117, P625
  • [8] High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex
    Costello, LC
    Hartman, TE
    Ryu, JH
    [J]. MAYO CLINIC PROCEEDINGS, 2000, 75 (06) : 591 - 594
  • [9] Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs
    Dabora, SL
    Jozwiak, S
    Franz, DN
    Roberts, PS
    Nieto, A
    Chung, J
    Choy, YS
    Reeve, MP
    Thiele, E
    Egelhoff, JC
    Kasprzyk-Obara, J
    Domanska-Pakiela, D
    Kwiatkowski, DJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (01) : 64 - 80
  • [10] Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling
    Gao, XS
    Zhang, Y
    Arrazola, P
    Hino, O
    Kobayashi, T
    Yeung, RS
    Ru, BG
    Pan, DJ
    [J]. NATURE CELL BIOLOGY, 2002, 4 (09) : 699 - 704